Article Type
Review
Subject Area
Nasal polyps
Abstract
According to previous categorizations of chronic rhinosinusitis (CRS), it ̓s divided into CRS with and without polyps, so this may not provide accurate evaluation for prognosis and management. An endotype in CRS refers to pathophysiologic mechanisms identified by certain biomarkers. Utilizing endotypes to categorize CRS variants represents an emerging understanding of the various pathophysiological pathways that cause clinical variability of CRS symptoms. This review highlights common endotype based criteria for the identification of various CRS subtypes and further explores the progress of treatment and prognosis with each classification approach. Utilizing the inflammatory biomarkers to endotype different CRS variants highlights the potential opportunities for development of biomarker-directed biologic therapies in CRS patients. Type 2 cytokine, eosinophils, Ig-E, and CysLT provide the four popular but overlapping methods to classify endotypes of CRS phenotypes. This review highlights common endotype-based criteria for the identification of various CRS subtypes and further explores the progress of treatment and prognosis with each classification approach.
Keywords
Biologics; Sinusitis; Interleukins; Biomarkers; Nasal Polyps
Recommended Citation
Tomoum M, Hazem E.
Approaches for Endotypes Classifications of Chronic Rhinosinusitis and Its Impact on Management and Prognosis.
Pan Arab J. Rhinol.
2024;
14 : -.
Available at:
https://pajr.researchcommons.org/journal/vol14/iss2/2
DOI: https://doi.org/10.58595/2090-7559.1235
Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-No Derivative Works 4.0 International License.
Included in
Oral and Maxillofacial Surgery Commons, Otolaryngology Commons, Otorhinolaryngologic Diseases Commons